Terns Pharmaceuticals

+$0.17 (+1.89%) As of 4:27 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TERN and other ETFs, options, and stocks.

About TERN

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program.

CEO
Senthil Sundaram
Employees
30
Headquarters
Foster City, California
Founded
2017

TERN Key Statistics

Market Cap
230.45M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
51.00K
High Today
$9.26
Low Today
$9.00
Open Price
$9.08
Volume
33.89K
52 Week High
$28.36
52 Week Low
$6.92

TERN Earnings

-$3.65
-$2.43
-$1.22
-$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure